Geron reported $297K in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amgen AMGN:US USD 6.65B 58M
Bio Techne TECH:US USD 269.65M 18.57M
Cti Biopharma CTIC:US USD 18.24M 5.91M
Cytokinetics CYTK:US USD 2.51M 86.45M
Esperion Therapeutics ESPR:US USD 18.98M 139K
Exelixis EXEL:US USD 411.74M 7.69M
Genmab GEN:DC DKK 4.09B 925M
Geron GERN:US USD 297K 224K
Gilead Sciences GILD:US USD 7.04B 782M
Macrogenics MGNX:US USD 41.73M 15.73M
Novartis NOVN:VX USD 12.84B 243M
Novavax NVAX:US USD 734.58M 548.65M
Seattle Genetics SGEN:US USD 510.3M 12.8M
YTE INCY:US USD 823.3M 88.09M